Concepedia

Patrick Papa

PP

Statistics

Publications

5

Citations

185

H-Index

5

Active since

2011

Affiliations

Bristol-Myers Squibb (United States)(Current)

Patrick Papa is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, medicinal chemistry, and potency optimization.

Publications per year

2011–2023

5

Publications

5

Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115

Deborah S. Mortensen, Sophie Perrin-Ninkovic, Graziella Shevlin et al. · Journal of Medicinal Chemistry · 2015 · 73 citations · Full text

, , +14

Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation

Stephen H. Norris, Xiaochu Ba, Jayce Rhodes et al. · Journal of Medicinal Chemistry · 2023 · 50 citations · Full text

, , +17

Discovery of Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor CC-223

Deborah S. Mortensen, Sophie Perrin-Ninkovic, Graziella Shevlin et al. · Journal of Medicinal Chemistry · 2015 · 33 citations · Full text

, , +16

Discovery and optimization of thieno[2,3-d]pyrimidines as B-Raf inhibitors

Garrick K. Packard, Patrick Papa, Jennifer R. Riggs et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 19 citations · Full text

, , +12

Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005

Patrick Papa, Brandon Whitefield, Deborah S. Mortensen et al. · Journal of Medicinal Chemistry · 2021 · 10 citations · Full text

, , +16

1–5 of 5